Results 271 to 280 of about 2,149,646 (301)
Some of the next articles are maybe not open access.
Cyclosporine in acute ischemic stroke
Neurology, 2015We examined whether IV administration of cyclosporine in combination with thrombolysis might reduce cerebral infarct size.Patients aged 18 to 85 years, presenting with an anterior-circulation stroke and eligible for thrombolytic therapy, were enrolled in this multicenter, single-blinded, controlled trial.
Nighoghossian, N. +30 more
openaire +3 more sources
Expert Review of Cardiovascular Therapy, 2010
Data from the European Cooperative Acute Stroke Study (ECASS) III trial demonstrated that tissue plasminogen activator given up to 4.5 h after stroke onset improves outcome and treatment guidelines support its use during this time window. Intra-arterial therapy with tissue plasminogen activator or devices is commonly used at large tertiary centers up ...
Henninger, Nils +2 more
openaire +3 more sources
Data from the European Cooperative Acute Stroke Study (ECASS) III trial demonstrated that tissue plasminogen activator given up to 4.5 h after stroke onset improves outcome and treatment guidelines support its use during this time window. Intra-arterial therapy with tissue plasminogen activator or devices is commonly used at large tertiary centers up ...
Henninger, Nils +2 more
openaire +3 more sources
Journal of Neuroscience Nursing, 2007
More than 700,000 people have a stroke each year in the United States. A diagnosis of stroke formerly elicited a nihilistic approach, but this has substantially changed in the last decade. Currently, time is brain, and it is important for all disciplines to work together to initiate acute stroke protocols in the emergency department and identify ...
Janice L, Hinkle, Mary McKenna, Guanci
openaire +2 more sources
More than 700,000 people have a stroke each year in the United States. A diagnosis of stroke formerly elicited a nihilistic approach, but this has substantially changed in the last decade. Currently, time is brain, and it is important for all disciplines to work together to initiate acute stroke protocols in the emergency department and identify ...
Janice L, Hinkle, Mary McKenna, Guanci
openaire +2 more sources
Immunothrombosis in Acute Ischemic Stroke
StrokeIschemic stroke is one of the leading causes of disability and mortality worldwide. Thrombosis is the main pathological process of stroke and is therefore an important therapeutic target in stroke prevention. In recent years, with the development of endovascular treatment and therefore retrieving the thrombus for further investigation, evidence is ...
Yan Wang +4 more
openaire +2 more sources
Treatment of Acute Ischemic Stroke
Continuum, 2017This article provides an update on the state of the art of the emergency treatment of acute ischemic stroke with particular emphasis on the alternatives for reperfusion therapy.The results of several randomized controlled trials consistently and conclusively demonstrating that previously functional patients with disabling strokes from a proximal ...
openaire +2 more sources
Thrombectomy for Acute Ischemic Stroke
JAMA, 2015Joanna M, Wardlaw, Martin S, Dennis
openaire +2 more sources
Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke, 2004Jauch Ec +2 more
exaly
Mechanical Thrombolysis in Acute Ischemic Stroke With Endovascular Photoacoustic Recanalization
Stroke, 2004Lawrence Wechsler +2 more
exaly
Neutrophil-to-Lymphocyte Ratio Is a Prognostic Marker in Acute Ischemic Stroke
Journal of Stroke and Cerebrovascular Diseases, 2017Jie Xue, Shao Bei, Zhengyi Cai
exaly

